391 related articles for article (PubMed ID: 10785491)
1. Recurrent invasive adenocarcinoma after hysterectomy for cervical adenocarcinoma in situ.
Krivak TC; Retherford B; Voskuil S; Rose GS; Alagoz T
Gynecol Oncol; 2000 May; 77(2):334-5. PubMed ID: 10785491
[TBL] [Abstract][Full Text] [Related]
2. Adenocarcinoma in situ of the cervix: management and outcome.
Azodi M; Chambers SK; Rutherford TJ; Kohorn EI; Schwartz PE; Chambers JT
Gynecol Oncol; 1999 Jun; 73(3):348-53. PubMed ID: 10366458
[TBL] [Abstract][Full Text] [Related]
3. Management and follow-up of patients with adenocarcinoma in situ of the uterine cervix.
Poynor EA; Barakat RR; Hoskins WJ
Gynecol Oncol; 1995 May; 57(2):158-64. PubMed ID: 7729727
[TBL] [Abstract][Full Text] [Related]
4. Pelvic sidewall adenocarcinoma after definitive therapy for cervical adenocarcinoma in situ.
Miller B; Dunn J; Dalrymple J; Krivak TC
Gynecol Oncol; 2005 Nov; 99(2):489-92. PubMed ID: 16054200
[TBL] [Abstract][Full Text] [Related]
5. Endocervical curettage, cone margins, and residual adenocarcinoma in situ of the cervix.
Denehy TR; Gregori CA; Breen JL
Obstet Gynecol; 1997 Jul; 90(1):1-6. PubMed ID: 9207802
[TBL] [Abstract][Full Text] [Related]
6. Invasive cervical adenocarcinoma immediately following a cone biopsy for adenocarcinoma in situ with negative margins.
Cohn DE; Morrison CD; Zanagnolo VL; Goist MM; Copeland LJ
Gynecol Oncol; 2005 Jul; 98(1):158-60. PubMed ID: 15913738
[TBL] [Abstract][Full Text] [Related]
7. Adenocarcinoma in situ of the uterine cervix: an experience with 100 cases.
Ostör AG; Duncan A; Quinn M; Rome R
Gynecol Oncol; 2000 Nov; 79(2):207-10. PubMed ID: 11063645
[TBL] [Abstract][Full Text] [Related]
8. [Endocervical adenocarcinoma in situ. A histological entity to know].
Fignon A; Mayelo V; Wurst C; Magnin G; Tariel D; Descamps P; Renjard L; Body G; Lansac J
J Gynecol Obstet Biol Reprod (Paris); 1995; 24(4):369-73. PubMed ID: 7650312
[TBL] [Abstract][Full Text] [Related]
9. Management of adenocarcinoma in situ (ACIS) of the uteri cervix--a clinical dilemma.
Tay EH; Yew WS; Ho TH
Singapore Med J; 1999 Jan; 40(1):36-9. PubMed ID: 10361484
[TBL] [Abstract][Full Text] [Related]
10. Adenocarcinoma in situ of the uterine cervix.
Muntz HG; Bell DA; Lage JM; Goff BA; Feldman S; Rice LW
Obstet Gynecol; 1992 Dec; 80(6):935-9. PubMed ID: 1448263
[TBL] [Abstract][Full Text] [Related]
11. [A falsely reassuring cervical smear in adenocarcinoma of the external os].
Rooker D; Baalbergen A; Helmerhorst TJ
Ned Tijdschr Geneeskd; 2008 Apr; 152(17):977-80. PubMed ID: 18549169
[TBL] [Abstract][Full Text] [Related]
12. Adenocarcinoma in situ of the uterine cervix: management and outcome.
Widrich T; Kennedy AW; Myers TM; Hart WR; Wirth S
Gynecol Oncol; 1996 Jun; 61(3):304-8. PubMed ID: 8641606
[TBL] [Abstract][Full Text] [Related]
13. Conservative management of adenocarcinoma in situ of the cervix.
Shin CH; Schorge JO; Lee KR; Sheets EE
Gynecol Oncol; 2000 Oct; 79(1):6-10. PubMed ID: 11006022
[TBL] [Abstract][Full Text] [Related]
14. Management of patients with positive margins after cervical conization.
Lapaquette TK; Dinh TV; Hannigan EV; Doherty MG; Yandell RB; Buchanan VS
Obstet Gynecol; 1993 Sep; 82(3):440-3. PubMed ID: 8355949
[TBL] [Abstract][Full Text] [Related]
15. Cervical adenocarcinoma in situ.
Hopkins MP; Roberts JA; Schmidt RW
Obstet Gynecol; 1988 Jun; 71(6 Pt 1):842-4. PubMed ID: 3285263
[TBL] [Abstract][Full Text] [Related]
16. Is the invasion depth in millimeters valid to determine the prognosis of early invasive cervical adenocarcinoma? A case of recurrent FIGO stage IA1 cervical adenocarcinoma.
Utsugi K; Shimizu Y; Akiyama F; Hasumi K
Gynecol Oncol; 2001 Jul; 82(1):205-7. PubMed ID: 11426988
[TBL] [Abstract][Full Text] [Related]
17. [Recurrent carcinoma in situ of the uterine cervix (author's transl)].
Anastasiadis P; von Lüdinghausen M
Geburtshilfe Frauenheilkd; 1979 Jun; 39(6):479-83. PubMed ID: 478259
[TBL] [Abstract][Full Text] [Related]
18. Invasive adenocarcinoma of the cervix following LLETZ (large loop excision of the transformation zone) for adenocarcinoma in situ.
Kennedy AW; elTabbakh GH; Biscotti CV; Wirth S
Gynecol Oncol; 1995 Aug; 58(2):274-7. PubMed ID: 7622120
[TBL] [Abstract][Full Text] [Related]
19. Cervical conization of adenocarcinoma in situ: a predicting model of residual disease.
Tierney KE; Lin PS; Amezcua C; Matsuo K; Ye W; Felix JC; Roman LD
Am J Obstet Gynecol; 2014 Apr; 210(4):366.e1-366.e5. PubMed ID: 24370689
[TBL] [Abstract][Full Text] [Related]
20. Prospective management of stage IA(1) cervical adenocarcinoma by conization alone to preserve fertility: a preliminary report.
Schorge JO; Lee KR; Sheets EE
Gynecol Oncol; 2000 Aug; 78(2):217-20. PubMed ID: 10926806
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
